Citing Illinois’ “deep talent pool” as a key draw, the CEO of Durata Therapeutics of Morristown, NJ has announced the start-up will move its global headquarters to Chicago.
Durata is a biopharmaceutical company addressing the growing need in global health care for new therapies to treat infection diseases. As drug-resistant bacteria continue to complicate both in-patient and out-patient health care settings, this high-growth industry is focused on developing new therapeutics to meet these challenges. Durata was established in 2009 and began trading on NASDAQ in July.
Gov. Pat Quinn said in a news release that life sciences is an important part of the global marketplace and Durata’s choice to move to Illinois reinforces the state’s role as a hub for biotech innovation. According to the Illinois Biotechnology Industry Organization, the Illinois biotech cluster includes more than 3,400 establishments and more than 80,000 employees. Durata Therapeutics will bring about 100 jobs to Illinois over the next three years.